AcquisitionOther
Kuva Labs Inc. acquired Lisata Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Kuva Labs Inc. -> Lisata Therapeutics, Inc. · $5.00 per share in cash plus $1.00 per share contingent value right
To acquire a clinical-stage pharmaceutical company with innovative therapies for advanced solid tumors.
Open source record (SEC) ↗